Jonathan Weiss / Shutterstock
Eli Lillys The Phase III SURPASS 2 clinical trial shows treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like...
Christopher J. Twomey, director of Tandem Diabetes Care, Inc. (NASDAQ: TNDM), sold 3,198 shares of Tandem Diabetes Care stock on Wednesday, April 21. ...